Cargando…
Update of the EMQN/ACGS best practice guidelines for molecular analysis of Prader-Willi and Angelman syndromes
This article is an update of the best practice guidelines for the molecular analysis of Prader-Willi and Angelman syndromes published in 2010 in BMC Medical Genetics [1]. The update takes into account developments in terms of techniques, differential diagnoses and (especially) reporting standards. I...
Autores principales: | Beygo, Jasmin, Buiting, Karin, Ramsden, Simon C., Ellis, Rachael, Clayton-Smith, Jill, Kanber, Deniz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777528/ https://www.ncbi.nlm.nih.gov/pubmed/31235867 http://dx.doi.org/10.1038/s41431-019-0435-0 |
Ejemplares similares
-
Practice guidelines for the molecular analysis of Prader-Willi and Angelman syndromes
por: Ramsden, Simon C, et al.
Publicado: (2010) -
EMQN best practice guidelines for genetic testing in dystrophinopathies
por: Fratter, Carl, et al.
Publicado: (2020) -
EMQN/CMGS best practice guidelines for the molecular genetic testing of Huntington disease
por: Losekoot, Monique, et al.
Publicado: (2013) -
EMQN best practice guidelines for the molecular genetic diagnosis of hereditary hemochromatosis (HH)
por: Porto, Graça, et al.
Publicado: (2016) -
EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency
por: Baumgartner-Parzer, Sabina, et al.
Publicado: (2020)